Institut Bergonié — Clinical Trial Site

10 Registered trials

7 Currently recruiting

Organisation

Institut Bergonié

Location

BORDEAUX, France

Identifier

ORL-000004832

Address

229 Cours de l'Argonne, 33000, France

Departments

Hematologie
Hematology-oncology department
Medical Oncology
Oncologie Médical
ONCOLOGIE MEDICALE
ONCOLOGY

Clinical trials at this site (10)

Search interface

CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) P… Pending

2024-516328-32-00 CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) 4
Phase 2, Multicenter, Open label, Platform Study investigating ASP3082 in patients with Metastatic/Locally Advanced Non-Small-Cell Lung Canc… Recruiting

2025-522533-54-00 Metastatic Non-small cell lung cancer (NSCLC) and Pancr 4 2026-03-17
A Phase 1/2 clinical trial of DT-7012 as monotherapy and in combination with an immune checkpoint inhibitor in participants with selected ad… Recruiting

2025-523758-15-00 Cancer 7 2026-02-11
A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program… Recruiting

2025-521281-97-00 Non-Small Cell Lung Cancer (NSCLC) 5 2025-12-02
INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1 Recruiting

2024-511989-36-00 Ewing Sarcoma 5 2025-09-24
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects … Recruiting

2023-505334-10-01 Unresectable, Locally Advanced, or Metastatic Solid Tum 7 2024-10-30
SALVOVAR trial: A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose & dosing schedule with the SALVa… Recruiting

2023-508260-30-01 Patients with poor prognostic OVARian cancers based on 5 2024-07-30
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL C… Ended

2024-514032-25-00 Patients with a histilogically confirmed diagnosis of c 4 2024-12-11
EPI-7386 in Combination with Enzalutamide versus Enzalutamide alone in Metastatic Castration-Resistant Prostate Cancer Ended

2023-509336-25-00 Metastatic castration-resistant prostate cancer 9 2024-06-12